GRP94 has been known to chaperone intracellular peptides as well as tumour-specific peptide and present them on the MHC class I molecules of antigen presenting cells (APCs) in a process called “cross-presentation” [165,166,167]. This evidence concerns the gene HSP90B1 and neoplasm.